ICIL.NS(ICIL.NS)
ICIL.NS
No analyst ratings available
No analyst price targets available for ICIL.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $50.25B | $60.97B | $82.75B | $77.78B |
| Low | $47.98B | $58.01B | $78.86B | $74.12B |
| High | $52.77B | $63.71B | $86.67B | $81.46B |
| EBITDA Avg | $7.93B | $9.62B | $13.05B | $12.27B |
| Low | $7.57B | $9.15B | $12.44B | $11.69B |
| High | $8.33B | $10.05B | $13.67B | $12.85B |
| EBIT Avg | $6.63B | $8.04B | $10.91B | $10.26B |
| Low | $6.33B | $7.65B | $10.40B | $9.77B |
| High | $6.96B | $8.40B | $11.43B | $10.74B |
| Net Income Avg | $2.90B | $4.35B | $5.08B | $8.19B |
| Low | $2.52B | $3.38B | $4.77B | $7.69B |
| High | $3.31B | $5.00B | $5.39B | $8.70B |
| EPS Avg | $14.63 | $21.98 | $25.66 | $41.40 |
| Low | $12.74 | $17.10 | $24.09 | $38.87 |
| High | $16.71 | $25.26 | $27.24 | $43.95 |
| Analysts (Rev / EPS) | 5 / 5 | 5 / 5 | 2 / 1 | 2 / 1 |